Jaxon Smith-Njigba must have initially thought that he was having a bad dream. The young 1,000-yard receiver was taking an early-evening nap Friday when the Seahawks traded away his starting ...

Celgene has also filed for approval of the R² regimen for these indolent forms of NHL in Europe and Japan, with an EMA verdict possible before the end of the year. Image Phil Taylor ...

Celgene's European leader Tuomo Pätsi talks to pharmaphorum about the firm's remarkable growth, which is set to continue thanks to myeloma blockbuster Revlimid and new psoriasis and psoriatic ...

BMS plans to separate its R&D into early- and late-stage divisions, with Celgene’s Rupert Vessey earmarked to lead the former and new recruit Samit Hirawat – formerly head of oncology R&D of ...

A two-way shootout for WH Smith's high street chain will take place this spring as the 233-year-old retailer’s brand prepares to disappear from towns across Britain. Sky News has learnt that ...

Formerly known as JCAR017 it was originally developed by Celgene’s Juno unit, and is under review by the FDA for relapsed or refractory large B-cell lymphoma after at least two prior ther apies.

NHS patients in England with newly-diagnosed multiple myeloma can be treated with Celgene’s Revlimid as maintenance therapy after a stem cell transplant, after new guidance from NICE.

GOP lawmaker says Republicans in his district aren't happy with Trump's handling of Russia and Ukraine ...